Integra Lifesciences Holdings (IART) Invested Capital (2009 - 2026)

Integra Lifesciences Holdings has disclosed Invested Capital across 18 years of filings, most recently posting $2.8 billion for Q2 2026.

• In Q2 2026, Invested Capital rose 3.36% year-over-year to $2.8 billion; the TTM figure through Jun 2026 stood at $2.8 billion (up 3.36% YoY), while the FY2025 annual figure was $2.9 billion, down 10.78% from the prior year.
• Invested Capital came in at $2.8 billion for Q2 2026 at Integra Lifesciences Holdings, roughly flat from $2.8 billion in the prior quarter.
• In the past five years, Invested Capital ranged from a high of $3.2 billion in Q1 2025 to a low of $2.5 billion in Q4 2023.
• Average Invested Capital over 5 years is $2.8 billion, with a median of $2.7 billion recorded in 2024.
• Year-over-year, Invested Capital increased 28.79% in 2024 and fell 13.67% in 2025.
• Over 5 years, Invested Capital stood at $2.6 billion in 2022, then dropped by 5.28% to $2.5 billion in 2023, then climbed by 28.12% to $3.2 billion in 2024, then slipped by 10.78% to $2.9 billion in 2025, then retreated by 1.32% to $2.8 billion in 2026.
• Per Business Quant data, the three most recent Invested Capital figures were $2.8 billion in Q2 2026, $2.8 billion in Q1 2026, and $2.9 billion in Q4 2025.